ASKA Pharmaceutical Holdings Co.,Ltd.
TSE:4886.T
2134 (JPY) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) JPY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||||
| Net Income
| 7,545 | 5,357 | 6,163 | 2,713 | 649 | 1,744 | 2,388 | 2,944 | 701 | 1,193 | 495 | 1,114 |
| Depreciation & Amortization
| 2,662 | 3,127 | 2,885 | 3,362 | 3,761 | 2,618 | 2,394 | 2,501 | 2,057 | 1,815 | 2,459 | 2,434 |
| Deferred Income Tax
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Working Capital
| -6,209 | -4,502 | -3,022 | -139 | -5,248 | -2,276 | -3,226 | 6,036 | -3,697 | -924 | 1,146 | 130 |
| Accounts Receivables
| -370 | -742 | -1,361 | 639 | -8,472 | -622 | -915 | -919 | -83 | -1,041 | 1,836 | -649 |
| Inventory
| -2,713 | -2,627 | -687 | -330 | 2,215 | -2,137 | -1,185 | 171 | 249 | -2,144 | 338 | 623 |
| Accounts Payables
| 1,494 | -980 | 412 | 392 | -1,057 | 1,887 | -74 | 1,502 | -3,073 | 0 | 0 | 0 |
| Other Working Capital
| -4,620 | -153 | -1,386 | -840 | 2,066 | -1,404 | -1,052 | 5,282 | -790 | 2,261 | -1,028 | 156 |
| Other Non Cash Items
| 4,401 | -631 | -3,184 | 6,628 | 15,182 | 6,526 | 5,482 | 4,830 | 6,611 | 3,626 | -1,484 | 191 |
| Operating Cash Flow
| 1,486 | 3,351 | 2,842 | 6,541 | -492 | 2,504 | 76 | 12,063 | -1,349 | 5,710 | 2,616 | 3,869 |
| Investing Activities: | ||||||||||||
| Investments In Property Plant And Equipment
| -1,453 | -746 | -2,377 | -1,104 | -2,264 | -15,723 | -1,510 | -733 | -5,605 | -1,945 | -1,818 | -1,138 |
| Acquisitions Net
| -1,463 | -285 | -53 | -2,342 | 0 | -2 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| -852 | -400 | -56 | -1 | -65 | -599 | -3,002 | -1,251 | -1,810 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 4,630 | 190 | 11 | 599 | 0 | 1,648 | 810 | 2,090 | 958 | 0 | 0 | 0 |
| Other Investing Activites
| 845 | 115 | 9,218 | -18 | -597 | -104 | 354 | -483 | -319 | 48 | -483 | -346 |
| Investing Cash Flow
| 1,706 | -1,126 | 6,743 | -2,866 | -2,927 | -14,780 | -3,348 | -378 | -6,776 | -1,897 | -2,301 | -1,484 |
| Financing Activities: | ||||||||||||
| Debt Repayment
| -3,138 | -1,423 | -2,298 | -23 | -48 | -13,519 | -750 | -2,008 | -4,342 | -558 | -58 | -58 |
| Common Stock Issued
| 9 | 1,368 | 248 | 52 | 54 | 4 | 0 | 13 | 60 | 0 | 0 | 0 |
| Common Stock Repurchased
| 9 | 55 | -248 | 52 | 54 | -2 | 0 | 13 | 60 | 23 | 38 | 69 |
| Dividends Paid
| -792 | -452 | -398 | -484 | -398 | -395 | -392 | -390 | -389 | -389 | -388 | -386 |
| Other Financing Activities
| -22 | -1,368 | -300 | -100 | 6 | -90 | -750 | -1,199 | 900 | 367 | -166 | 499 |
| Financing Cash Flow
| -3,943 | -1,820 | -2,996 | -455 | -392 | 13,036 | -1,142 | -2,384 | 4,013 | -557 | -574 | 124 |
| Other Information: | ||||||||||||
| Effect Of Forex Changes On Cash
| -15 | -2 | 0 | 0 | -2 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| -767 | 402 | 6,589 | 3,220 | -3,813 | 761 | -4,415 | 9,299 | -4,112 | 3,256 | -259 | 2,509 |
| Cash At End Of Period
| 16,738 | 17,505 | 17,103 | 10,514 | 7,294 | 11,107 | 10,346 | 14,761 | 5,462 | 3,256 | -259 | 2,509 |